ReceptorPharma Inc logo — Do something of consequent to help the world. Proactively in...

ReceptorPharma Inc

Do something of consequent to help the world. Proactively including the scientific boundaries for global breakthroughs

Founded 2017 United States Dover, United States 1 employees Seed Pharmaceutical

General Information

Company Name ReceptorPharma Inc
Founded Year 2017
Location United States Dover, United States +1
Employees 1
Industries Pharmaceutical
Funding Stage Seed
Social

Get notified when ReceptorPharma Inc moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ReceptorPharma Inc

ReceptorPharma Inc is a pharmaceutical startup founded in 2017 with a mission to develop new Alzheimer’s drugs through a novel pathway and mechanism. Utilizing the latest research on disease-coupled genes and a well-studied drug target protein family, the company aims to create a new generation of Alzheimer’s disease drugs. This innovative approach serves as their competitive advantage, positioning them at the forefront of drug development for Alzheimer’s and other debilitating diseases, including certain types of cancer. The Seed Round investment in June 2018 from SmiLe Venture Hub signifies the industry's recognition of their potential. With headquarters in the United States, ReceptorPharma is proactively pushing scientific boundaries for global breakthroughs in pharmaceuticals.

Taxonomy: Alzheimer's disease, drug discovery, pharmaceuticals, genetic research, drug targeting, neurodegenerative diseases, cancer treatment, novel pathway, competitive advantage

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1
Investor
01 Jun 2018

ReceptorPharma Inc Alternatives & Competitors

ReceptorPharma Inc vs

Committed to the development and commercialization of new drug therapeutics for unmet needs

4 employees
Biopharma, Industrial
ReceptorPharma Inc vs

Cantabio aim to slow, stop and even prevent the onset & progression of neurodegenerative diseases.

Grant
13 employees
Biotechnology, Pharmaceutical
ReceptorPharma Inc vs
NeuroActiva, Inc.
NeuroActiva, Inc. United States

Our goal is to make Alzheimer's disease a disease of the past.

2 employees
Biotechnology

FAQ About ReceptorPharma Inc

Do something of consequent to help the world. Proactively including the scientific boundaries for global breakthroughs
ReceptorPharma Inc was founded in 2017.
ReceptorPharma Inc is headquartered in Dover, United States.
ReceptorPharma Inc operates in the following industries: Pharmaceutical.
ReceptorPharma Inc has approximately 1 employees.
ReceptorPharma Inc has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to ReceptorPharma Inc include Biomed Industries Inc, Cantabio Pharmaceuticals, Inc., NeuroActiva, Inc., Intelligent OMICS Ltd, Brain Chemistry Labs. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ReceptorPharma Inc and Biomed Industries Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ReceptorPharma Inc and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy